[Federal Register Volume 62, Number 197 (Friday, October 10, 1997)] [Notices] [Pages 53015-53016] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 97-26889] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Statement of Organization, Functions, and Delegations of Authority Part N, National Institutes of Health, of the Statement of Organization, Functions, and Delegations of Authority for the Department of Health and Human Services (40 FR 22859, May 27, 1975, as amended most recently at 62 FR 47509, September 9, 1997, and redesignated from Part HN as Part N at 60 FR 56605, November 9, 1995), is amended as set forth below to reflect the reorganization of the National Cancer Institute as follows: (1) the Division of Cancer Control and Population Science (DCCPS) and DCCPS's Office of the Director are established; (2) the Division of Cancer Prevention and Control is retitled to the Division of Cancer Prevention (DCP), its functional statement is revised, and the DCP's Office of the Director functional statement is revised; (3) the Division of Cancer Treatment, Diagnosis and Centers is retitled to the Division of Cancer Treatment and Diagnosis and its functional statement is revised; (5) in the Office of the Director, the Office of Centers, Training and Resources is established; and (6) in the Office of the Director, the Office of Special Populations Research is established. Section N-B, Organization and Functions, under the heading National Cancer Institute (NC, formerly HNC) is amended as follows: (1) The following is inserted: Division of Cancer Control and Population Science (NCD, formerly HNCD). (1) Plans and directs an extramural program of cancer and population science research for the Institute; (2) serves as the Institute focal point for extramural research in the following areas: epidemiology and cancer genetics, behavioral sciences and cancer surveillance; (3) develops and supports multidisciplinary research training and career development in cancer control; (4) provides leadership in setting national priorities for research in the areas central to cancer control and in conducting regulatory program reviews to assess the impact of funded initiatives; and (5) coordinates program activities with other Divisions, Institutes, or Federal and state agencies, and establishes liaison with professional and voluntary health agencies, cancer centers, labor organizations, cancer organizations and trade associations. Office of the Director (NCD1, formerly HNCD1). (1) Plans, develops, directs, and coordinates the Institute's research activities related to cancer control and population science conducted through independent and cooperative studies and programs with cancer centers, universities, state and other health agencies, private industry and other Federal agencies; (2) develops and maintains liaison with public health groups and agencies, cancer centers, public and professional educational organizations, labor organizations, trade and professional associations, voluntary health organizations, healthcare delivery and managed-care organizations, and regulatory agencies in order to facilitate communication, information exchange, and cooperation; (3) collaborates with other divisions, offices, institutes, and/or national and international research organizations in projects and activities related to cancer control; (4) plans, develops, directs and coordinates the Institute's research activities related to cancer survivors; and (5) disseminates relevant research information to the lay and professional communities. (2) The title and functional statement for the Division of Cancer Prevention and Control (NC4, formerly NHC4) and its Office of the Director (NC41, formerly HNC41) are replaced with the following: Division of Cancer Prevention (NC4, formerly HNC4). (1) Plans and directs an extramural program of cancer prevention research for the Institute; (2) develops and supports research training and career development in cancer prevention; (3) coordinates program activities with other Divisions, Institutes, or Federal and state agencies, and establishes liaison with professional and voluntary health agencies, cancer centers, labor organizations, cancer organizations, healthcare delivery and managed-care organizations, and trade associations; and (4) coordinates community-based clinical research in cancer prevention and dissemination of cancer treatment practice through a consortium of community clinical centers. [[Page 53016]] Office of the Director (NC41, formerly HNC41). (1) Plans, develops, directs, and coordinates the Institute's research activities related to prevention in community clinical oncology centers, conducted through independent and cooperative studies and programs with cancer centers, universities, state and other health agencies private industry and other Federal agencies; (2) develops and maintains liaison with public health groups and agencies, cancer centers, public and professional educational organizations, labor organizations, trade and professional associations,. voluntary health organizations, and regulatory agencies in order to facilitate communication, information exchange, and cooperation; (3) collaborates with other Divisions, Offices, Institutes, and/or national and international research organizations in projects and activities related to cancer prevention; and (4) disseminates relevant prevention, early detection, psychosocial, and rehabilitation information to the lay and professional communities. (3) The title and functional statement for the Division of Cancer Treatment, Diagnosis and Centers (NCB, formerly HNCB) are replaced with the following: Division of Cancer Treatment and Diagnosis (HNCB). (1) Plans, directs and coordinates a program of extramural preclinical and clinical cancer treatment research as well as research conducted in cooperation with other Federal agencies with the objective of curing or controlling cancer in man by utilizing treatment modalities singly or in combination; (2) administers targeted research and development programs in the areas of drug development, diagnosis, biological response modifiers and radiotherapy development; and (3) serves as the national focal point for information and data on experimental and clinical studies related to cancer treatment and for the distribution of such information to appropriate scientists and physicians. (4) In the Office of the Director (NC1, formerly HNC1) the following are inserted: Office of Centers, Training and Resources (NC18, formerly HNC18). (1) Plans, directs, coordinates, evaluates and supports extramural grant programs that relate to the broad scientific objectives of each extramural Division and that are designed to develop and enhance cancer research in academic and research institutions; (2) through the extramural funding of specialized and/or broad multidisciplinary centers devoted to the basic, clinical and populations sciences, advances the knowledge and understanding of the causes, mechanisms, diagnosis and treatment of cancer and promotes transitional research or the movement of discoveries in the laboratory into patient and population research settings; (3) assists extramural research efforts through support of the improvement, renovation, and construction of research facilities; (4) provides training opportunities for health professionals in order to create a national cadre of highly skilled individuals capable of transferring research discoveries to applications in cancer diagnosis, treatment, and prevention; and (5) establishes program priorities, allocates resources, integrates the projects of various branches, evaluates program effectiveness relative to the goals and objectives of the Institute, and represents the program area in management and scientific decision-making meetings within the Institute. Office of Special Populations Research (NC19, formerly HNC19). (1) Provides leadership, coordination, and advice to the Director, NCI, on research related to minorities and special populations; (2) serves as the Institute's focal point for programs addressing scientific questions pertinent to minority and ethnic populations as well as the elderly and medically underserved; (3) provides advice and assistance to the Institute Director, Division Directors, and other senior staff concerning the development, conduct and research focus of programs pertaining to or affecting special populations; (4) collaborates and consults, as necessary, with appropriate Institute, NIH, and other Federal and non-federal agencies and organizations interested or engaged in research on special populations; and (5) develops concepts for new programs that would be implemented by the scientific divisions of the Institute. Dated: September 30, 1997. Harold Varmus, Director, National Institutes of Health. [FR Doc. 97-26889 Filed 10-9-97; 8:45 am] BILLING CODE 4140-01-M